CHRO logo

Chromocell Therapeutics (CHRO) Selling, General & Administrative Expenses

Annual SGA

$4.28 M
+$2.36 M+122.32%

December 31, 2023


Summary


Performance

CHRO SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCHROexpensesmetrics:

Quarterly SGA

$1.63 M
-$117.44 K-6.71%

September 30, 2024


Summary


Performance

CHRO Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCHROexpensesmetrics:

TTM SGA

-$67.00 M
-$10.07 M-17.68%

September 30, 2024


Summary


Performance

CHRO TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCHROexpensesmetrics:

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

CHRO Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+122.3%+3.1%-1664.4%
3 y3 years+202.6%+232.8%-5895.1%
5 y5 years+202.6%+232.8%-5895.1%

CHRO Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+579.9%-6.7%+989.9%-1720.6%at low
5 y5-yearat high+579.9%-6.7%+989.9%-1720.6%at low
alltimeall timeat high+579.9%-6.7%+989.9%-1720.6%at low

Chromocell Therapeutics Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$1.63 M(-6.7%)
$6.44 M(+6.5%)
Jun 2024
-
$1.75 M(+19.3%)
$6.05 M(+20.4%)
Mar 2024
-
$1.47 M(-7.4%)
$5.02 M(+17.3%)
Dec 2023
$4.28 M
$1.58 M(+27.5%)
$4.28 M(+18.4%)
Sep 2023
-
$1.24 M(+70.9%)
$3.62 M(+26.2%)
Jun 2023
-
$727.20 K(-0.2%)
$2.87 M(+19.0%)
DateAnnualQuarterlyTTM
Mar 2023
-
$728.50 K(-20.8%)
$2.41 M(+25.1%)
Dec 2022
$1.93 M(+205.8%)
$920.20 K(+87.5%)
$1.93 M(+66.6%)
Sep 2022
-
$490.90 K(+81.7%)
$1.16 M(+73.8%)
Jun 2022
-
$270.10 K(+10.1%)
$665.30 K(+68.3%)
Mar 2022
-
$245.30 K(+63.6%)
$395.20 K(+163.6%)
Dec 2021
$629.90 K(-55.5%)
$149.90 K
$149.90 K
Dec 2020
$1.42 M
-
-

FAQ

  • What is Chromocell Therapeutics annual SGA?
  • What is the all time high annual SGA for Chromocell Therapeutics?
  • What is Chromocell Therapeutics annual SGA year-on-year change?
  • What is Chromocell Therapeutics quarterly SGA?
  • What is the all time high quarterly SGA for Chromocell Therapeutics?
  • What is Chromocell Therapeutics quarterly SGA year-on-year change?
  • What is Chromocell Therapeutics TTM SGA?
  • What is the all time high TTM SGA for Chromocell Therapeutics?
  • What is Chromocell Therapeutics TTM SGA year-on-year change?

What is Chromocell Therapeutics annual SGA?

The current annual SGA of CHRO is $4.28 M

What is the all time high annual SGA for Chromocell Therapeutics?

Chromocell Therapeutics all-time high annual SGA is $4.28 M

What is Chromocell Therapeutics annual SGA year-on-year change?

Over the past year, CHRO annual SGA has changed by +$2.36 M (+122.32%)

What is Chromocell Therapeutics quarterly SGA?

The current quarterly SGA of CHRO is $1.63 M

What is the all time high quarterly SGA for Chromocell Therapeutics?

Chromocell Therapeutics all-time high quarterly SGA is $1.75 M

What is Chromocell Therapeutics quarterly SGA year-on-year change?

Over the past year, CHRO quarterly SGA has changed by +$49.09 K (+3.10%)

What is Chromocell Therapeutics TTM SGA?

The current TTM SGA of CHRO is -$67.00 M

What is the all time high TTM SGA for Chromocell Therapeutics?

Chromocell Therapeutics all-time high TTM SGA is -$3.68 M

What is Chromocell Therapeutics TTM SGA year-on-year change?

Over the past year, CHRO TTM SGA has changed by -$71.29 M (-1664.44%)